Vivimed Labs Ltd. benchmarking: Perfomance to industry peers

Financial

	Vivimed Labs	Deccan Health Care	JFL Life Sciences
Operational Metrics
Pharmaceuticals
US DMF Filings	150.0 .	n/a	n/a
R&D as a % of Total Sales	0.14 %	n/a	n/a
Financials
5 yr Average ROE	10.89 %	0.79 %	12.26 %
5yr average Equity Multiplier	-33.72	1.17	2.68
5yr Average Asset Turnover Ratio	0.27	0.47	0.93
5yr Avg Net Profit Margin	-54.08 %	1.37 %	5.75 %
Price to Book	0.23	0.36	0.88
P/E	0.0	27.78	10.47
5yr Avg Cash Conversion Cycle	184.52 Days	218.27 Days	138.58 Days
Inventory Days	244.76 Days	372.92 Days	96.42 Days
Days Receivable	246.32 Days	54.52 Days	135.23 Days
Days Payable	159.64 Days	94.94 Days	103.44 Days
5yr Average Interest Coverage Ratio	-6.61	12.96	4.03
5yr Avg ROCE	-13.87 %	2.08 %	17.72 %
5yr Avg Operating Profit Margin	-26.56 %	7.39 %	10.31 %
5 yr average Debt to Equity	-13.68	0.02	0.9
5yr CAGR Net Profit	-14.97 %	24.36 %	50.43 %
5yr Average Return on Assets	-10.44 %	0.68 %	5.01 %
Shareholdings
Promoter Holding	7.77 %	18.42 %	67.47 %
Share Pledged by Promoters	14.8 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-13.19 %	-9.18 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Vivimed Labs	Deccan Health Care	JFL Life Sciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Speciality Chemicals 0 Nutraceuticals 0 Pharmaceutical Products 0	Product Wise Break-Up Speciality Chemicals 0 Nutraceuticals 100.0 Pharmaceutical 0 Pharmaceutical Products 0	Product Wise Break-Up Speciality Chemicals 0 Nutraceuticals 0 Pharmaceutical 0 Pharmaceuticals 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 70.0 India 30.0	Location Wise Break-Up Rest of the World 0.14 India 99.86	-
Operating Profit Break-Up	Operating Profit Break-Up Specialty Chemicals 100.0 Pharma 0	-	-
Capex	Capex Pharma 88.18 Specialty Chemicals 11.82	-	-
Asset Break-Up	Asset Break-Up Pharma 91.29 Specialty Chemicals 8.71	-	-